Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics
19 juil. 2021 08h00 HE
|
Brooklyn Immunotherapeutics LLC
Acquisition Advances Transformation Into Platform Company Focused on Cell, Gene Editing and Cytokine Therapy Company to hold Conference Call Today, July 19, 2021, at 4:15PM ET to Discuss the...